Current vaccines teach T cells to fight Omicron (IMAGE)
Caption
The Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2.
Credit
La Jolla Institute for Immunology
Usage Restrictions
Only in news stories reporting on the study
License
Licensed content